| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2K | +100.0% | +100.0% |
| Cost of Revenue | $1K | -75.0% | -50.0% |
| Gross Profit | $1K | +133.3% | +200.0% |
| R&D Expense | $2K | -99.1% | -98.7% |
| SG&A Expense | $211K | +117.5% | -29.2% |
| Operating Income | -$237K | +32.9% | +61.1% |
| Net Income | -$4.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $468K | +5750.0% | +735.7% |
| Inventory | $64K | +16.4% | +392.3% |
| Current Assets | $570K | +578.6% | +555.2% |
| Total Assets | $636K | +318.4% | +83.3% |
| Current Liabilities | $8.4M | +94.7% | — |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$350K | — | — |
| Investing Cash Flow | -$82K | — | — |
| Financing Cash Flow | $735K | — | — |
| — |
| -813.7% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| $8.4M |
| +94.7% |
| +232.2% |
| Stockholders' Equity | -$7.7M | -86.8% | -257.5% |